Basic Information
REGADEX CAPSULE 75MG
CAPSULE
Regulatory Information
SIN15776P
August 14, 2019
Prescription Only
Therapeutic
ORAL
August 10, 2023
June 3, 2025
Company Information
Active Ingredients
PREGABALIN
Strength: 75 mg
Detailed Information
Contraindications
**4.3 Contraindications** Hypersensitivity to the active substance or to any of the excipients.
Indication Information
**4.1 Therapeutic indications** Neuropathic pain Pregabalin is indicated for the treatment of neuropathic pain, which includes diabetic peripheral neuropathy and post-herpetic neuralgia, in adults. Epilepsy Pregabalin is indicated as adjunctive therapy of partial seizures, with or without secondary generalisation, in adults. Generalised anxiety disorder Pregabalin is indicated for the treatment of Generalised Anxiety Disorder (GAD) in adults. Fibromyalgia Pregabalin is indicated for the management of fibromyalgia.